Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-29
2011-03-29
Landau, Sharmila Gollamudi (Department: 1611)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S212040, C514S220000
Reexamination Certificate
active
07915280
ABSTRACT:
This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP.
REFERENCES:
patent: 6121278 (2000-09-01), Jackson et al.
patent: 6197785 (2001-03-01), Jackson et al.
patent: 6201020 (2001-03-01), Zhang et al.
patent: 6306889 (2001-10-01), Li et al.
patent: 6346536 (2002-02-01), Li et al.
patent: 6348475 (2002-02-01), Zhang et al.
patent: 6380193 (2002-04-01), Li et al.
patent: 6387902 (2002-05-01), Zhang et al.
patent: 6395749 (2002-05-01), Li et al.
patent: 6495541 (2002-12-01), Webber et al.
patent: 6514983 (2003-02-01), Li et al.
patent: 6635642 (2003-10-01), Jackson et al.
patent: 6887996 (2005-05-01), Ferraris et al.
patent: 6979683 (2005-12-01), Barth et al.
patent: 7235557 (2007-06-01), Ferraris et al.
patent: RE41150 (2010-02-01), Ferraris et al.
patent: WO 99 11624 (1999-03-01), None
patent: WO 99/11624 (1999-03-01), None
patent: WO 99 59975 (1999-11-01), None
patent: WO 00 42040 (2000-07-01), None
patent: WO 01 23390 (2001-04-01), None
patent: WO 02 44183 (2002-06-01), None
Haince et al. Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy. Trends in Molecular Medicine. 2005; 11(10): 456-463, electronic copy, pp. 1-15.
Olsson et al. DNA damage and repair in tumor and non-tumor tissues of mice induced by nicotinamide. Br. J. Cancer. Aug. 1996; 74(3) 368-73, abstract only.
Penning et al. The role of DNA damage and inhibition of poily(ADP-ribosyl)ation in loss of clonogenicity of murine L929 fibroblasts, caused by photodynamically induced oxidative stress. Cancer Research. 1994; 54: 5561-5567.
Pettitt et al. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues. Cancer Resarch. 2000; 60:4187-4193, electronic copy, pp. 1-15.
Morissette et al. “High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids” Advanced Drug Delivery Reviews, 2004, 56, 275-300.
Seddon et al. “Pseudopolymorph: A Polemic” Crystal Growth and Design, 2004, 4, 1087.
Vippagunta et al. “Crystalline solids” Advanced Drug Delivery Reviews, 2001, 48, 3-26.
Ames et al., Tetrahedron, vol. 40, No. 10, 1984, pp. 1919-1925.
Park et al., J Org. Chem, vol. 66, 2001, pp. 2197-2206.
U.S. Appl. No. 11/066,478, filed Feb. 28, 2005.
Ferraris Dana Victor
Kalish Vincent
Li Jia-He
Zhang Jie
Connolly Bove & Lodge & Hutz LLP
Eisai Inc.
Klinkel Kortney L
Landau Sharmila Gollamudi
LandOfFree
Compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2737179